P J Eifel, S McClure. Show Affiliations »
Abstract
Entities: Disease Species
Mesh： See more » Antineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useBleomycin/administration & dosageBleomycin/adverse effectsCyclophosphamide/administration & dosageCyclophosphamide/adverse effectsDoxorubicin/administration & dosageDoxorubicin/adverse effectsHumansLeucovorin/administration & dosageLeucovorin/adverse effectsLymphoma, Non-Hodgkin/drug therapyLymphoma, Non-Hodgkin/pathologyLymphoma, Non-Hodgkin/radiotherapyMaleMethotrexate/administration & dosageMethotrexate/adverse effectsMiddle AgedMouth Mucosa/drug effectsMouth Mucosa/pathologyMouth Mucosa/radiation effectsPrednisone/administration & dosagePrednisone/adverse effectsRadiation Injuries/pathologyRecurrenceStomatitis/etiologyStomatitis/pathologyTonsillar Neoplasms/drug therapyTonsillar Neoplasms/pathologyTonsillar Neoplasms/radiotherapyVincristine/administration & dosageVincristine/adverse effects
Substances： See more » BleomycinVincristineDoxorubicinCyclophosphamideLeucovorinPrednisoneMethotrexate
Year: 1989 PMID： 2476427 DOI： 10.1016/0360-3016(89)90086-2
Source DB: PubMed Journal: Int J Radiat Oncol Biol Phys ISSN： 0360-3016 Impact factor: 7.038